McKesson Corporation (MCK) FCF Payout Ratio: 6.83%
Is McKesson Corporation’s FCF payout ratio high or low?
McKesson Corporation's FCF payout ratio of 6.83% is in line with its 5-year average of 7.07%, near the low end of its 5-year range (6.35%–8.66%).
2.99% above its 12-month average of 6.63%.
MCK FCF Payout Ratio Chart
MCK Average FCF Payout Ratio Chart
MCK Current vs Average FCF Payout Ratio Chart
MCK FCF Payout Ratio Metrics
FCF PAYOUT RATIO
6.83%
FCF PAYOUT RATIO AVG TTM
6.63%
FCF PAYOUT RATIO AVG 3Y
7.07%
FCF PAYOUT RATIO AVG 5Y
7.07%
FCF PAYOUT RATIO AVG 10Y
7.24%
FCF PAYOUT RATIO AVG 15Y
7.63%
FCF PAYOUT RATIO AVG 20Y
7.48%
CURRENT VS TTM AVG
+2.99%
CURRENT VS 3Y AVG
-3.35%
CURRENT VS 5Y AVG
-3.46%
CURRENT VS 10Y AVG
-5.61%
CURRENT VS 15Y AVG
-10.48%
CURRENT VS 20Y AVG
-8.71%
Payout Ratio Comparison
FCF Payout Ratio
6.8%
Earnings Payout Ratio
8.5%
Dividend Yield
0.44%
FCF Yield
6.44%
Annual FCF Payout Ratio History
| Year | Free Cash Flow | Dividends Paid | FCF Payout Ratio |
|---|---|---|---|
| 2026 | $5.72B | $381.00M | 6.7% |
| 2025 | $5.23B | $345.00M | 6.6% |
| 2024 | $3.63B | $314.00M | 8.7% |
| 2023 | $4.60B | $292.00M | 6.3% |
| 2022 | $3.90B | $277.00M | 7.1% |
| 2021 | $3.90B | $276.00M | 7.1% |
| 2020 | $3.87B | $294.00M | 7.6% |
| 2019 | $3.48B | $292.00M | 8.4% |
| 2018 | $3.77B | $262.00M | 7.0% |
| 2017 | $4.18B | $253.00M | 6.0% |
| 2016 | $3.00B | $244.00M | 8.1% |
| 2015 | $2.57B | $227.00M | 8.8% |
| 2014 | $2.72B | $214.00M | 7.9% |
| 2013 | $2.08B | $194.00M | 9.3% |
| 2012 | $2.55B | $195.00M | 7.7% |
| 2011 | $1.95B | $171.00M | 8.8% |
| 2010 | $1.94B | $131.00M | 6.8% |
| 2009 | $959.00M | $116.00M | 12.1% |
| 2008 | $513.00M | $70.00M | 13.6% |
| 2007 | $1.23B | $72.00M | 5.8% |
| 2006 | $2.58B | $73.00M | 2.8% |
| 2005 | $1.40B | $70.60M | 5.0% |
| 2004 | $448.40M | $69.80M | 15.6% |
| 2003 | $579.50M | $79.70M | 13.8% |
| 2002 | $197.50M | $78.50M | 39.7% |
| 2001 | $194.20M | $78.30M | 40.3% |
| 2000 | ($561.10M) | $77.50M | N/A (Loss) |
| 1999 | ($236.30M) | $94.80M | N/A (Loss) |
| 1998 | ($230.20M) | $46.30M | N/A (Loss) |
| 1997 | ($1.05B) | $43.30M | N/A (Loss) |
Formula: FCF Payout Ratio = Dividends Paid / Free Cash Flow × 100
FCF payout and earnings payout:
- FCF represents operating cash flow after capital expenditures
- FCF payout compares dividends paid with free cash flow
- FCF payout above 100% means dividends paid exceeded free cash flow for the period
- Earnings payout compares dividends paid with net income
Reading the series: Use the chart and table to compare dividend payments with cash generation over time.
McKesson Corporation FCF Payout Ratio Formula & Definition
FCF Payout Ratio measures what percentage of free cash flow is paid out as dividends. Unlike earnings-based payout, it compares dividends with cash generated after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
McKesson Corporation FCF Payout Ratio FAQ
- What is the FCF payout ratio for McKesson Corporation (MCK)?
- The FCF payout ratio for MCK stock is 6.83%.
- Is McKesson Corporation's FCF payout ratio high or low?
- McKesson Corporation's FCF payout ratio of 6.83% is in line with its 5-year average of 7.07%, near the low end of its 5-year range (6.35%–8.66%).
- What is the TTM average FCF payout ratio for McKesson Corporation (MCK)?
- The TTM average FCF payout ratio for MCK stock is 6.63%.
- What is the 3Y average FCF payout ratio for McKesson Corporation (MCK)?
- The 3Y average FCF payout ratio for MCK stock is 7.07%.
- What is the 5Y average FCF payout ratio for McKesson Corporation (MCK)?
- The 5Y average FCF payout ratio for MCK stock is 7.07%.
- What is the 10Y average FCF payout ratio for McKesson Corporation (MCK)?
- The 10Y average FCF payout ratio for MCK stock is 7.24%.
- What is the 15Y average FCF payout ratio for McKesson Corporation (MCK)?
- The 15Y average FCF payout ratio for MCK stock is 7.63%.
- What is the 20Y average FCF payout ratio for McKesson Corporation (MCK)?
- The 20Y average FCF payout ratio for MCK stock is 7.48%.
McKesson Corporation FCF Payout Ratio History
| DATE | FCF PAYOUT RATIO |
|---|---|
| 2026-03-31 | 6.66% |
| 2025-03-31 | 6.60% |
| 2024-03-31 | 8.66% |
| 2023-03-31 | 6.35% |
| 2022-03-31 | 7.10% |
| 2021-03-31 | 7.08% |
| 2020-03-31 | 7.60% |
| 2019-03-31 | 8.39% |
| 2018-03-31 | 6.96% |
| 2017-03-31 | 6.05% |
| 2016-03-31 | 8.15% |
| 2015-03-31 | 8.84% |
| 2014-03-31 | 7.86% |
| 2013-03-31 | 9.34% |
| 2012-03-31 | 7.66% |
| 2011-03-31 | 8.77% |
| 2010-03-31 | 6.76% |
| 2009-03-31 | 12.10% |
| 2008-03-31 | 13.65% |
| 2007-03-31 | 5.84% |
| 2006-03-31 | 2.83% |
| 2005-03-31 | 5.05% |
| 2004-03-31 | 15.57% |
| 2003-03-31 | 13.75% |
| 2002-03-31 | 39.75% |
| 2001-03-31 | 40.32% |
About McKesson Corporation
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Brian S. Tyler